Field report NW-90 / K7 · sheet /deals

M&A & DealsFiled from the territory

NHS extends Palantir contract to 2029, spurning break clause

Ministers declined to exercise a break clause on Palantir's £330m NHS data contract, extending it to 2029 amid warnings that the health service stays locked to one US supplier.

Grid
NW-90 / K7
Surveyed
November 19, 2026
Reading
4 min read
Correspondent
Olivia Hart
NHS warned over Palantir lock-in as £330m contract extended
Fig. NW-90 / K7NHS warned over Palantir lock-in as £330m contract extended — Salvador Rios / unsplash

Field notes

  1. Palantir's £330m NHS data contract, secured in 2023, has been extended to 2029 instead of ending in 2027
  2. The break clause that would have allowed exit in 2027 was not exercised, on grounds of service disruption risk
  3. More than half of NHS trusts in England now use the platform, which NHS figures credit with 110,000 additional operations
  4. Procurement for a replacement Federated Data Platform is due to begin next year, open to British and international suppliers
  5. Parliament is set to debate Palantir's removal following criticism from Labour MPs, Dame Chi Onwurah and Amnesty International UK

By Olivia Hart

The government will not exercise a break clause to end Palantir's £330m NHS contract in 2027, extending the deal to 2029 and handing the US firm two more years to run the health service's Federated Data Platform (FDP).

Ministers confirmed the decision this week. Health minister James Frith said ending the agreement in 2027 would risk disrupting services, and the government plans to begin procurement for a replacement next year.

Palantir secured the seven-year contract in 2023 to develop software linking data across NHS organisations. The platform was intended to reduce waiting lists and improve hospital efficiency, and more than half of NHS trusts in England now use it. NHS figures suggest the technology has helped deliver 110,000 additional operations.

What does extending the contract to 2029 change?

For suppliers watching the NHS data market, the exit date has moved two years to the right. The government has said it will encourage British technology companies to compete for the replacement contract, while also inviting international suppliers to participate.

Labour MPs and campaigners have criticised the delay, and Parliament is set to debate Palantir's removal from NHS systems. The argument has shifted from the calendar to whether a break clause nobody can safely pull is worth having at all.

Why do critics describe this as vendor lock-in?

Dame Chi Onwurah, chair of Parliament's Science and Technology Committee, said the government's own reasoning exposed the problem.

"The suggestion that exercising the break clause now would be too impractical only reinforces our concerns about vendor lock-in," she said. "The government should not wait two years – it must start reducing this dependency now."

Peter Griffiths, founder and chairman of Argyll Data Development, made a related point: swapping one platform for another changes little unless the data itself can move.

"The NHS Palantir debate is really a question about the control of data," he said. "The NHS is such a critical part of the UK's national infrastructure that no single supplier should hold the keys to its data and systems."

Griffiths said ministers must test whether data, applications and critical workloads can be transferred without disrupting patient care before awarding another contract. "Sovereignty must be a priority for the government, and an exit clause only counts if the NHS can actually leave when it wants to," he added.

Who is expected to bid for the replacement contract?

The government has promised to encourage British technology companies to compete for the replacement, while keeping the process open to international suppliers. Rupal Karia, senior vice-president at German software firm Celonis, welcomed that approach.

"Keeping flagship British tenders, like the £330m NHS data contract, open to trusted European partners naturally complements Britain's push for fair access to 'Made in Europe' procurement," Karia said.

Karia argued digital sovereignty should prevent dependence on individual suppliers rather than exclude overseas companies. "True digital sovereignty isn't about isolationism – it is built through trusted partnerships, open platforms that prevent single-vendor lock-in, and ensuring public institutions like the NHS always retain full control of their own data," he said.

What political pressure is Palantir facing?

The extension has also drawn criticism over Palantir's work with the Israeli military and US immigration authorities. Amnesty International UK welcomed the government's commitment to ending the contract but urged NHS organisations not to expand their use of the platform in the meantime.

Tom Guha, the organisation's crisis campaigner, said: "This is a victory for healthcare workers, patients and campaigners who refused to give up." "This is welcome progress, but the job is not finished. The next two years must be about extracting Palantir from our NHS, not allowing it to become more deeply embedded," he added.

How does Palantir answer the criticism?

Palantir has defended its NHS work, arguing that its platform is exceeding performance targets. The company says it is helping hospitals deliver more operations, speed up discharges and reduce delays in cancer diagnosis. Tom Watson, senior vice-president at Palantir UK, said the company was "proud of our work to date".

What it means for the supply chain

For the supply chain, the practical consequence is a two-year reprieve for Palantir and a replacement tender that opens next year. Suppliers that can show transferable data, open platforms and NHS control of records enter the frame; the fight over the exit clause has become a procurement specification.

Parliament's debate will test whether ministers accept that specification before the tender is written. Frith's disruption warning and Griffiths' transfer test pull in opposite directions, and the 2029 exit date now sits between them.

via cityam.com (Source)

Share this article:

More from Olivia Hart

Olivia Hart

Show full bio

News editor covering regulation, policy and their impact on corporate strategy and chief-executive leadership at CEO Frontier.

458 articles

Filed under

Adjacent sheets

« Previous articleNext article »

End of sheetNW-90 / K7 · November 19, 2026